Enterprise of Rosatom State Corporation
Back to website

Industry news


NorthStar Awarded $21.8 Million for Domestic Molybdenum

Northstar Medical Technologies was awarded $21.8 million in part by the U.S. Department of Energy's National Nuclear Security Administration (NNSA). The grant was provided in an effort to develop a sustainable American supply of molybdenum-99 using alternative medical isotope production methods that do not require the use of high-enriched uranium, according to a Nov. 21 announcement.

For more information visit www.molecularimaging.net


comments powered by Disqus